<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03638102</url>
  </required_header>
  <id_info>
    <org_study_id>2018-0992</org_study_id>
    <nct_id>NCT03638102</nct_id>
  </id_info>
  <brief_title>Sleep Duration in Women With Previous Gestational Diabetes</brief_title>
  <official_title>The Effect of Sleep Extension on Glucose Metabolism in Women With Previous Diagnosis of Gestational Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women with a history of gestational diabetes (GDM) are at high risk of developing diabetes in
      the future. Sleep disturbances are emerging as risk factors for incident diabetes. The
      purpose of this study is to test the effects of 6-week sleep extension in women with a
      history of GDM and short sleep on glucose metabolism by randomized controlled study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim of this study is to evaluate the effects of a sleep extension intervention in
      non-diabetic women with a prior history of GDM and habitual short sleep duration on the
      outcomes of glucose metabolism. The participants will be randomized to a 6-week sleep
      extension intervention group, using technology-assisted sleep intervention, or a healthy
      living information control group. Glucose metabolism parameters will be assessed by an oral
      glucose tolerant test.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Glucose metabolism parameters</measure>
    <time_frame>6 weeks</time_frame>
    <description>Changes in serum glucose and insulin levels from oral glucose tolerant test (at 0,30,60,90 and 120 minutes) between baseline and 6 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep duration</measure>
    <time_frame>6 weeks</time_frame>
    <description>Changes in sleep duration from baseline to 6 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucose metabolism post intervention</measure>
    <time_frame>10 weeks (4 weeks post intervention)</time_frame>
    <description>Fasting glucose and insulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Energy metabolism post intervention</measure>
    <time_frame>10 weeks (4 weeks post intervention)</time_frame>
    <description>Weight and caloric intake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective sleep quality</measure>
    <time_frame>Baseline, week 6 and week 10</time_frame>
    <description>Pittsburgh sleep quality index (range 0 to 21 with higher score reflecting worse sleep quality)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Energy metabolism</measure>
    <time_frame>6 weeks</time_frame>
    <description>Changes in weight, caloric intake, appetite, energy metabolism from baseline to 6 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depressive symptoms</measure>
    <time_frame>Baseline, week 6 and week 10</time_frame>
    <description>Center for Epidemiologic Studies Depression Scale (range 0-60 with higher score reflecting more depressive symptoms)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>Sleep intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sleep extension</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy living</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Health education</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sleep extension</intervention_name>
    <description>Sleep extension aims to increase sleep duration for at least 30 minutes using weekly coaching</description>
    <arm_group_label>Sleep intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Healthy living</intervention_name>
    <description>Participants will receive weekly health education</description>
    <arm_group_label>Healthy living</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Premenopausal women, age 18-45, with a history of GDM who currently do not have
             diabetes

          -  At least one year post-partum

          -  Reported habitual sleep duration &lt;7h/night during work- or weekdays with a desire to
             sleep longer

          -  Reported time spent in bed =&lt;8 hours

          -  Own a smartphone compatible with Fitbit.

          -  No need to provide care at night for her child(ren), defined as &gt;3 times a week and
             &gt;30 minutes at a time

          -  No history of obstructive sleep apnea, insomnia, or restless leg syndrome

        Exclusion Criteria:

          -  A1C ≥6.5%

          -  Currently pregnant or planning pregnancy or breast feeding

          -  Insomnia symptoms defined as severe as assessed by the Insomnia Severity Index (score
             ≥15)

          -  Rotating shift or night shift work

          -  High risk for obstructive sleep apnea screened by STOP BANG questionnaire.

          -  Significant medical morbidities, such as congestive heart failure, cirrhosis, chronic
             obstructive pulmonary disease requiring oxygen, active treatment for cancer or
             psychiatric problem, history of stroke with neurological deficits, cognitive
             impairment, kidney failure requiring dialysis, illicit drug use.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Non-diabetic women with a previous history of gestational diabetes</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sirimon Reutrakul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sirimon Reutrakul</last_name>
    <phone>3124135357</phone>
    <email>sreutrak@uic.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sirimon Reutrakul, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009 May 23;373(9677):1773-9. doi: 10.1016/S0140-6736(09)60731-5.</citation>
    <PMID>19465232</PMID>
  </reference>
  <reference>
    <citation>Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999 Oct 23;354(9188):1435-9.</citation>
    <PMID>10543671</PMID>
  </reference>
  <reference>
    <citation>Reutrakul S, Van Cauter E. Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. Ann N Y Acad Sci. 2014 Apr;1311:151-73. doi: 10.1111/nyas.12355. Epub 2014 Mar 14. Review.</citation>
    <PMID>24628249</PMID>
  </reference>
  <reference>
    <citation>Amnakkittikul S, Chirakalwasan N, Wanitcharoenkul E, Charoensri S, Saetung S, Chanprasertyothin S, Chailurkit LO, Panburana P, Bumrungphuet S, Reutrakul S. Postpartum resolution of obstructive sleep apnea in women with gestational diabetes and the relationship with glucose metabolism. Acta Diabetol. 2018 Jul;55(7):751-754. doi: 10.1007/s00592-018-1127-x. Epub 2018 Mar 15.</citation>
    <PMID>29546578</PMID>
  </reference>
  <reference>
    <citation>Baron KG, Duffecy J, Reid K, Begale M, Caccamo L. Technology-Assisted Behavioral Intervention to Extend Sleep Duration: Development and Design of the Sleep Bunny Mobile App. JMIR Ment Health. 2018 Jan 10;5(1):e3. doi: 10.2196/mental.8634.</citation>
    <PMID>29321122</PMID>
  </reference>
  <reference>
    <citation>Mohr DC, Duffecy J, Ho J, Kwasny M, Cai X, Burns MN, Begale M. A randomized controlled trial evaluating a manualized TeleCoaching protocol for improving adherence to a web-based intervention for the treatment of depression. PLoS One. 2013 Aug 21;8(8):e70086. doi: 10.1371/journal.pone.0070086. eCollection 2013.</citation>
    <PMID>23990896</PMID>
  </reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>August 12, 2018</study_first_submitted>
  <study_first_submitted_qc>August 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2018</study_first_posted>
  <last_update_submitted>June 26, 2019</last_update_submitted>
  <last_update_submitted_qc>June 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Sirimon Reutrakul</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>sleep duration</keyword>
  <keyword>glucose metabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

